Related Experiment Videos
Molecular imaging applications for immunology
Isabel Junie Hildebrandt1, Sanjiv Sam Gambhir
1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
Clinical Immunology (Orlando, Fla.)
|May 13, 2004
Summary
Molecular imaging, including positron emission tomography (PET) and bioluminescent imaging (BIm), enhances noninvasive study of cellular events. These techniques improve diagnostics and drug screening for diseases like cancer and inflammatory conditions.
Area of Science:
- Immunology
- Medical Imaging
- Biotechnology
Background:
- Multimodality molecular imaging allows noninvasive, repetitive study of molecular and cellular events in vivo.
- Traditional diagnostic assays are enhanced by molecular imaging's improved diagnostic capabilities.
- Imaging modalities like PET, SPECT, MRI, ultrasound, CT, BIm, and FIm are used in small animal and human imaging.
Purpose of the Study:
- To review current molecular imaging assays, focusing on PET and BIm.
- To examine the impact of molecular imaging on animal models of human disease.
- To explore the role of molecular imaging in clinical immunology.
Main Methods:
- Review of current literature on molecular imaging techniques.
- Focus on positron emission tomography (PET) and bioluminescent imaging (BIm) modalities.
- Analysis of applications in small animal models and human disease.
Main Results:
- Molecular imaging enables in-depth study of intracellular events.
- Cell trafficking patterns in inflammatory diseases and metastases can be examined.
- Rapid screening of drug distribution and efficacy is facilitated.
Conclusions:
- Molecular imaging significantly advances the study of molecular and cellular events.
- PET and BIm are key modalities with broad applications in research and clinical settings.
- Molecular imaging holds substantial promise for advancing clinical immunology and understanding disease mechanisms.